Thursday, August 6, 2026
NewsWhite
Novo Nordisk's raised forecast fails to change the debate over its obesity business
BUSINESS
Unverified

Novo Nordisk's raised forecast fails to change the debate over its obesity business

August 5, 2026·Source: CNBC·16 views

Wall Street isn't convinced the Ozempic maker has a promising path back to sustainable growth as competition from Eli Lilly intensifies.

This story was originally reported by CNBC. For the complete coverage and latest updates, visit the original source.

Read the full story at CNBC.

Originally reported by CNBC. Read the original article

Related Articles